|
 |
| home > ebr > spring 2003 > meptides: a novel class of synthetic peptide derivatives for the potential treatment of neurodegenerative diseases |
|
|
 PUBLICATIONS |
European BioPharmaceutical Review
|
| A number of seemingly unrelated neurodegenerative diseases, including Alzheimer's, Parkinson's and Huntington's diseases, CJD (the human form of 'mad cow' disease) and ALS (motor neurone disease) have all recently been linked to a common pathogenic process called amyloidosis. In each case a specific protein or peptide clumps together in a specific part of the brain to form toxic soluble oligomers and/or insoluble fibres, which are widely believed to cause the progressive degeneration of neurons associated with these diseases. Several academic groups and at least one biotech company are now working on a novel class of synthetic peptide derivatives ('meptides') which can inhibit and reverse this process of protein/peptide aggregation in vitro, and which have the potential to yield effective treatments or perhaps even outright cures for all these diseases. |
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
Small Scale Biomanufacturing – clinical trials, cell & gene therapies
18 September 2008, Clifton Pavilion, Bristol Zoo Gardens, Bristol
This one day conference, sponsored by bioProcessUK and organised by BioApproaches South West, will cover key, important topics relating to small scale GMP biomanufacturing.
More info >> |
|
 |
News and Press Releases |
 |
New PFA SonicLine® ultrasonic flowmeters
Flow measurement with ultrasound fast, precise, free from contamination The new PFA SonicLine® ultrasonic flowmeters assure precise measurement and control of chemical consumption and management of chemical stocks with high reliability. SonicLine® is also ideally suited for accurate batch and dosing processes with high reproducibility.
More info >> |
|
|
